Document is current
Any future updates will be listed below
-
Authors
Ando, Tadao
Uzawa, Kohji https://orcid.org/0000-0002-1000-9485
Yoshikawa, Takahiro
Mitsuda, Shingo
Akimoto, Yoshihiro
Yorozu, Tomoko
Ushiyama, Akira
-
Funding
Funding for this research was provided by:
Grant-in-Aid for Young Scientists (JP26861248)
Grant-in-Aid for Scientific Research (JP16K10973)
- License Information
-
More Information
Article History
Received: 8 May 2022
Accepted: 12 November 2022
First Online: 24 November 2022
Declarations
:
: The authors declare that they have no competing interests. Corresponding author Kohji Uzawa received a powder of Voluven<sup>®</sup> (hydroxyethylated starch: 130/0.4/6) from Fresenius Kabi (Bad Homburg, Germany) without charge. Kyorin University Hospital has received funding for research from Otsuka Pharmaceutical Factory Inc. (Tokushima, Japan), which sells Voluven<sup>®</sup> in Japan.
: All animal experiments were performed in accordance with the Animal Research: Reporting of In Vivo Experiments guidelines. Ethical approval for this study (Ethical Committee for Animal Experiments, protocol number: 30–006) was obtained from the Ethical Committee of the National Institute of Public Health, Saitama, Japan, on 5 June 2018.
: Not applicable.
